iShares Nasdaq Biotechnology ETF (IBB)
| 157.06 BATS BZX Real-Time Price As of 3:06pm ET |  -2.17 / -1.36%Today’s Change | 126.00 Today|||52-Week Range 174.04 | +3.68% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Latest IBB News
| Biogen's Alzheimer's Drug Approval Puts Biotech ETFs in Spotlight Jun 17 / Zacks.com - Paid Partner Content | Could CureVac Be a Millionaire-Maker Stock? Jun 08 / MotleyFool.com - Paid Partner Content |
| Should You Buy Biotech ETFs Now? Jun 16 / Zacks.com - Paid Partner Content | Biogen's Alzheimer Drug Wins FDA Approval Jun 07 / Zacks.com - Paid Partner Content |
| ETFs to Win as Moderna Seeks COVID-19 Vaccine Nod for Teens Jun 10 / Zacks.com - Paid Partner Content |
Performance
| 1 month | +5.75% | 3 years | +12.70% | |
| 3 months | +0.68% | 5 years | +12.86% | |
| 1 year | +19.69% | Since inception | +8.12% |
Data through 06/17/2021
Quote Details
| Previous close | $159.23 |
| Open day’s range | 156.78 – 158.72 |
| Net asset value (NAV) | 158.13 (06/16/2021) |
| Daily volume | 134,521 |
| Average volume (3 months) | 3,669,717 |
Data as of 3:06pm ET, 06/18/2021
Peer Comparisonvs. Health ETFs
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +12.86% | +15.28% |
| Expense Gross exp ratio | 0.46% | 1.03% |
| Risk 5 year sharpe ratio | 0.52 | 0.76 |
| Net assets | $10.2B | $2.5B |
| Average market cap | $18.4B | $34.2B |
| Average P/E | 25.8 | 27.5 |
| Dividend / Share | -- | 0.29% |
Competitors
| IEHS iShares Evolved U.S. Healthcare Staples ... |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| FHLC Fidelity MSCI Health Care Index ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| AMGN Amgen | 8.80% |
| GILD Gilead Sciences | 6.97% |
| MRNA Moderna Inc | 6.21% |
| ILMN Illumina Inc | 4.97% |
| VRTX Vertex Pharmaceuticals Inc | 4.55% |
| REGN Regeneron Pharmaceuticals | 4.44% |
| BIIB Biogen | 3.42% |
| ALXN Alexion Pharmaceuticals Inc | 3.26% |
| SGEN Seagen Inc | 2.36% |
| AZN AstraZeneca | 2.19% |
